Cardinal Health said on October 1, 2026 it entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032. The company said the extension reflects the continuation of its current scope of distribution services.

1. 01

   Cardinal Health said on October 1, 2026 it entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032. The company said the extension reflects the continuation of its current scope of distribution services.

2. 02

   In connection with the renewal, Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth ($12.40 to $12.60). The company said this guidance maintains the previously issued range.

3. 03

   The company reaffirmed its long-term non-GAAP EPS growth rate guidance of 12% to 14%. Cardinal Health said it may provide further updates during its first quarter earnings call scheduled for November 5, 2026 on Q1.

4. 04

   Cardinal Health said the growth rate for its fiscal year 2027 guidance is based on adjusted fiscal year 2026 results. The company said these adjusted results exclude the fiscal year 2026 benefit from the IEEPA tariff refund.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.